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enzyme-linked immunosorbent assay (ELISA). Macrophage polariza-
tion and its mechanism were evaluated by ﬂow cytometry and west-
ern blot. Additionally, toll-like receptor 4 (TLR4) small interfering
RNA and mitogen-activated protein kinase (MAPK) inhibitors were
used to further conﬁrm the molecular mechanism of curcumin on
macrophage polarization.
RESULTS Curcumin dose-dependently inhibited M1 macrophage po-
larization and the production of TNF-a, IL-6, and IL-12. It also
decreased TLR4 expression, which regulates M1 macrophage polari-
zation. Furthermore, curcumin signiﬁcantly inhibited the phosphor-
ylation of ERK, JNK, p38, and nuclear factor (NF)-kB. In contrast,
siTLR4 in combination with p-JNK, p-ERK, and p-p38 inhibition
reduced the effect of curcumin on polarization.
CONCLUSIONS Curcumin can modulate macrophage polarization
through TLR4-MAPK/NF-kB pathway inhibition, indicating that its
effect on macrophage polarization is related to its anti-inﬂammatory
and atheroprotective effects. Our data suggest that curcumin could be
used as a therapeutic agent in atherosclerosis.GW26-e0196
Effects of Niacin on ApoE-/- Mice’ Adipose Tissue, Serum Lipid and
Atherosclerosis
Rui Du, Zhongqun Wang
Afﬁliated Hospital of Jiangsu University
OBJECTIVES To investigate the effects of Niacin on ApoE-/- mice’
adipose tissue, serum lipid and atherosclerosis, and furthermore to
explore the potential relation among them.
METHODS Total 28 male ApoE-/- mice were randomly divided into 3
groups: control group (n ¼8), model group (n ¼10), Niacin treatment
group (n ¼10), respectively fed with normal diet, high cholesterol diet,
high cholesterol diet þ1%(w/w) Niacin. After 14 weeks, serum lipid
level (total triglyeride, total cholesterol, HDL cholesterol, LDL
cholesterol and apoA-I) was measured by enzymatic method and by
immunoturbidimetery. Lesions of aortic arteries were stained with
hematoxylin eosin. The content of cholesterol in arterial wall and
subcutaneous adipose tissue in groin was quantitated by high per-
formance liquid chromatography. The expression of LXRa, ABCA1
and ABCG1 mRNA in subcutaneous adipose tissue was determined by
RT-PCR.
RESULTS The content of cholesterol in subcutaneous adipose tissue
in control group, model group, Niacin treatment group was (3.13 
0.19), (20.81  1.97) and (4.00  0.81) mg/g, respectively. Compared
with model group, Niacin treatment could increase the expression
of LXRa, ABCA1 and ABCG1 mRNA 144%, 47.3% and 73.8%,
respectively. And furthermore, it could also downregulate the level
of serum total triglyceride, total cholesterol and LDL cholesterol,
upregulate the level of serum HDL cholesterol, apoA-I. Pearson
correlation analysis showed that there was a positive relation be-
tween the content of cholesterol in arterial wall and the ratio
of intima/media thickness (r¼0.58, P<0.05). In addition to those
above, Niacin treatment could thin the intima thickness, decrease
the ratio of intima/media thickness and downregulate the sub-
endothelium lipid-accumulation, especially cholesterol -accumulation.
CONCLUSIONS Niacin treatment may promote the reverse cholesterol
transport of peri-adipose tissue, bring the changes of serum lipid
proﬁle, and furthermore inﬂuence the sub-endothelium lipid-accu-
mulation, especially cholesterol -accumulation, and subsequently
reverse the aortic atherosclerosis.GW26-e0454
Renalase Protects the Cardiomyocytes of Sprague-Dawley Rats Against
Ischemia and Reperfusion Injury by Reducing Myocardial Cell Necrosis and
Apoptosis
Xiaogang LI, Weihong Jiang
The Third Xiangya Hospital of Central South University
OBJECTIVES Renalase, a novel ﬂavoprotein expressed in the kidney
and heart, reduces renal tubular necrosis and apoptosis, which
suggests that it might protect against myocardial ischemia reper-
fusion injury (MIRI) in the same manner. This experiment sought
to explore the effects of renalase on Sprague-Dawley (SD) rats
subjected to MIRI.
METHODS We used Lentivirus-mediated RNA interference (RNAi) to
inhibit the renalase gene expression in the heart tissue via pericardialcavity injection. The MIRI animal modal was established by blocking
the left anterior descending artery for 45mins followed by 4h of
reperfusion. Real-time PCR and western blotting were used to detect
renalase expression in the heart tissue. Double staining and TUNEL
were used to detect the necrosis and apoptosis in the myocardial cells,
respectively.
RESULTS All rats subjected to MIRI exhibited lower levels of
renalase in the heart tissue than did the sham-operated group
(P<0.05, n¼6). The (RNAi) group rats exhibited lower renalase
levels than did the controls and also exhibited more serious ne-
crosis (7.120.56% vs. 3.320.93%, P<0.05, n¼6) and apoptosis
(151.88.2 vs. 66.86.5, P<0.05, n¼6); however, pretreatment
with the recombinant renalase signiﬁcantly reduced myocardial
cell necrosis (1.510.12% vs. 4.130.02%, P<0.05, n¼6) and
apoptosis (21.35.0 vs. 52.610.4, P<0.05, n¼6) relative to the
control rats.
CONCLUSIONS Exogenous recombinant renalase protein reduced
myocardial cell necrosis and apoptosis. Recombinant renalase protein
might be a new cardiovascular drug for ischemia/IR injury.GW26-e0734
Roles of (p)rr Gene Activation in the Heart in Hypertensive Rats
Yanling Zhang, Lulu Ma, Junyan Wu
Institute of Neurobiology, Taishan Medical University, Taian, China
OBJECTIVES Discovery of (pro)renin receptor (P)RR uncovered a
novel function of (pro)renin as receptor ligand in addition to enzyme
and its precursor, but the roles and mechanisms of (P)RR on the end-
organ damage remains unclear so far. Recently, some ﬁndings support
the (pro)renin-(P)RR interaction at exceptionally high (pro)renin
levels in vitro. However, the conﬂicting results obtained with handle
region peptide (HRP) in vivo and in vitro argue against the idea that
this drug truly blocks the (pro)renin-(P)RR interaction in the intact
animals. In this study, we investigated the roles of cardiac (P)RR and
its downward signals on cardiac hypertrophy in hypertensive rats
with abdominal aortic constriction, following treatment of HRP and
PLC-b3 inhibitor, U73122.
METHODS Seventy-ﬁve SD rats were divided into 5 groups (n¼15
each group) as following: sham operated (SO), rats with the aortic
ligation (AL), AL rats were given HRP (4mg kg-1 d-1, SC), AL rats given
U73122 (40mg kg-1 d-1, SC) and AL rats given HRPþU73122. MAP was
recorded using a tail-cuff method. After 4 weeks of treatment, levels
of (P)RR, PLC-b3, PKC-a and ERK1/2 in the heart were examined by
RT-PCR and western blot. The surface area of cardiomyocytes was
measured.
RESULTS The levels of (P)RR and PLC-b3 signiﬁcantly increased in the
left ventricle in hypertensive rats (P<0.01, respectively). The surface
area of cardiomyocytes and MAP rose markedly (P<0.01). HRP
signiﬁcantly decreased the level of (P)RR and U73122 suppressed PLC-
b3 expression. Treatment of both HRP and U73122 signiﬁcantly
decreased levels of PKC-a, ERK1/2 and Raf-1 in the heart (P<0.001).
Meanwhile, the surface area of cardiomyocytes and MAP were
decreased after treatment (P<0.01).
CONCLUSIONS This study demonstrates that (P)RR inhibitor, HRP
and PLC-b3 inhibitor, U73122 decreased levels of (P)RR, PLC-b3, PKC-
a, ERK1/2 and Raf-1 in the heart, respectively. Meanwhile, adminis-
tration of both reagents lowered the surface area of cardiomyocytes
and MAP. These ﬁndings indicate that cardiac (P)RR may activate
PLC-b3, PKC, ERK1/2 and Raf-1 signals and lead to hypertension and
cardiac hypertrophy.
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Protective Effects and Mechanism of Penehyclidine Hydrochloride on
Myocardial Ischemia Reperfusion Injury in rats
Duomao Lin, Yanyan Xue, Zhaoqi Wang, Jun Ma
Beijing Anzhen Hospital, Capital Medical University
OBJECTIVES To investigate the effects and mechanisms of penehy-
clidine hydrochloride (PHC) on myocardial ischemia reperfusion
injury(IRI).
METHODS A rat model of myocardial IRI was established by the
ligation of left anterior descending coronary artery for 30 min fol-
lowed by 3 h perfusion. The rats were randomly divided into 6 groups
(n¼18 in each group): a). Sham group: The rats underwent sham
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were administrated with high dose of penehyclidine hydrochloride
(H-PHC; 1 mg/kg bodyweight)by i.v. 30min before sham surgery; c).
Ischemia reperfusion (I/R) group: The rats were subjected to a
30min LAD coronary artery ligation followed by 3h reperfusion; d).
I/RþL-PHC group: The rats were administrated with low dose of
PHC (L-PHC; 0.1 mg/kg bodyweight) 30min before I/R; e). I/RþM-
PHC group: The rats were administrated with moderate dose of PHC
(M-PHC; 0.3 mg/kg bodyweight) 30min before I/R; f). I/RþH-PHC
group: The rats were injected with H-PHC (1 mg/kg bodyweight)
30min before I/R. Cardiac function was measured by echocardiog-
raphy after 3h reperfusion. Blood samples were collected. Then, the
activities and levels of myocardial enzymes and antioxidant en-
zymes in serum were detected. Evans blue/TTC double staining was
performed to assess infarct size. Cardiomyocyte apoptosis was
evaluated by TUNEL assay. The release of inﬂammatory cytokines
and inﬂammatory mediators was detected by ELISA. Western blot
was performed to analyze the expression of COX-2, p-IkB, IkB and
NF-kB.
RESULTS We found that PHC improved cardiac function by elevating
ejection fraction (EF), fractional shortening (FS) and left ventricular
end systolic pressure (LVESP), and downregulating left ventricular
end-diastolic pressure (LVEDP). PHC treatment remarkably decreased
the activities of creatine kinase (CK), aspartate aminotransferase
(AST), lactate dehydrogenase (LDH) and malondialdehyde (MDA)
content, and increased superoxide dismutase (SOD) activity. Addi-
tionally, PHC reduced the infarct size and the apoptotic rate of car-
diomyocytes in a dose dependent manner. Administration of PHC
signiﬁcantly decreased serum IL-1b, TNF-a, PEG-2 and IL-6 levels and
myocardium COX-2 level. Meanwhile, the expression levels of p-IkB
and NF-kB were downregulated, while IkB expression was upregu-
lated. These results suggest that PHC exert dose-dependent effects
on I/R-induced myocardial injury by inhibiting oxidative stress,
apoptosis and inﬂammation, and reduce the levels of nuclear NF-kB
and p-IkB.
CONCLUSIONS PHC presented signiﬁcantly dose dependent effects
on myocardial IRI by inhibiting inﬂammation, oxidative stress and
apoptosis, and reducing the level of nuclear NF-kB and p-IkB.GW26-e1245
Atractylenolide II and Atractylenolide III Inhibit Platelets Activities and
Thrombus Formation
Yizhu Chen,1 Xiaolin Wu,2 Junling Liu,2 Junfeng Zhang1
1NO.9 People Hospital Afﬁliated to Shanghai Jiao Tong University
School of Medicine; 2Department of Biochemistry and Molecular Cell
Biology of Shanghai Jiao Tong University School of Medicine
OBJECTIVES Antiplatelet treatment has been proved to be an effec-
tive strategy for the prevention of cardiovascular disease (CVD).
However, a major disadvantage of this strategy is the increasing risk of
hemorrhages. Developing new platelet inhibitors with minimal
adverse effects is important for clinical treatment of CVD. Atractyle-
nolideII(ATII) and III(ATIII) are the major active components in
Atracylodes macrocephala. The effects of the components including
anti-inﬂammatory and anti-cancer have been demonstrated. Howev-
er, their effects on platelet activation are unknown. Therefore, We
explored the effects of ATII and ATIII on platelet activities such as
platelet aggregation, platelet spreading, thrombus formation and so
on. We also investigated the effects of ATII and ATIII on essential
signaling mediator in platelet activation.
METHODS Human platelets were adjusted to 310⁸platelets/ml for
platelet aggregation. ATII, ATIII and Acetylsalicylic acid were incu-
bated with the platelets for 3 min prior to stimulation, respectively.
When the platelet aggregation was terminated, the target proteins
were detected to detect the phosphorylation levels of signaling mol-
ecules by Western blotting. For platelet spreading on immobilized
ﬁbrinogen, platelets were incubated with ATII and ATIII respectively
for 3min and allowed to spread on immobilized ﬁbrinogen. The colt
reaction was done as following, human platelet-depleted plasma was
mixed with washed human platelets to a concentration of 4108/ml
and was incubated with ATIIand AT III for 3min respectively. Plasma
was induced to coagulate with 0.4U/ml thrombin. We examined
thrombosis formation by FeCl3-induced carotid artery injury murine
thrombosis model. After mice were treatment with ATII(ATIII) at
60mg/kg dose by oral administration, carotid artery blood ﬂow was
monitored.
RESULTS Compared to Acetylsalicylic acid, ATII(ATIII) inhibited
platelet aggregation with lower concentration(10mM) in response toathrombin and collagen. Akt and other signaling molecules such as
p-38, Erk have been proved to play critical roles in platelet activa-
tion. Akt Ser473phosphorylation levels were signiﬁcantly diminished
for ATII(ATIII) treatment in response toathrombin, but no changes
were found in the phosphorylation levels of p-38 and Erk. The
average size of the platelets that spread on Fg were 1900.41059.86
pixels for ATII10mM,21851687.07 pixels for ATIII10mM versus
9508.762107.95 pixels for the platelets in the presence of DMSO. In
the FeCl3-induced carotid artery thrombosis model, the average time
to ﬁrst occlusion was 12.19 min for the ATII,and 9.67 min for ATIII
mice, in contrast to 6.76min in control mice. The average ratio of
clot retraction of ATII with platelets was 0.16590.0115, ATII
with platelets was 0.28920.0118 versus DMSO with platelets
0.71830.0359.
CONCLUSIONS The work demonstrates that ATII and AT III inhibit
platelets aggregation, spreading, clot retraction and arterial throm-
bosis formation in vivo. The results suggest that ATII& III have the
potential to be an efﬁcient platelet inhibitors.
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PHA665752, Hepatocyte Growth Factor/c-Met Inhibitor, Reduces the
Ventricular Fibrillation Threshold in Myocardial Infarction Rats Treated
with Cardiac Stem Cells Transplantation.
Shaoxin Zheng, Fei Wang, Huibao Long, Jingying Hou, Tong Wang
The Sun Yat-sen Memorial Hospital of Sun Yat-sen University,
Guangzhou, China
OBJECTIVES Our previous studies found that cardiac stem cells
(CSCs) transplantation improved the ventricular ﬁbrillation
threshold (VFT) in myocardial infarction (MI) rats. However, the
mechanisms remain unclear. Therefore, we sought to explore the
mechanisms.
METHODS MI was induced in 30 male Sprague-Dawley rats. 2 weeks
later, animals were randomized to receive 5106 CSCs labeled with
PKH26 in phosphate buffer solution(PBS)(20 rats) or PBS (10 rats)
alone injection into the infarcted anterior ventricular free wall.
After that, 10 rats with CSCs transplantation received PHA665752
(Hepatocyte Growth Factor/c-Met Inhibitor, 15mg/kg) in PBS and
DMSO (PHA665752 group), 10 rats with CSCs transplantation
received PBS and DMSO (CSC group) and 10 rats with PBS injection
received PBS and DMSO (PBS group) via tail vein injection every
day for 2 weeks. Then the VFTs were measured. Labeled CSCs were
observed in 5mm cryostat sections from each heart to detect the
myocardial ﬁbrosis.
RESULTS Comparisons of CSC group, the VFTs were deteriorative in
PHA665752 group
(PHA665752 group vs. CSC group vs. PBS group:
infarct zone: 3.91.7mA vs. 10.31.9mA vs. 3.40.7mA p＜0.05
infarct marginal zone: 4.21.4mA vs. 9.71.4mA vs. 2.90.7mA
p＜0.05
non-infarct zone: 2.90.9mA vs. 9.11.1mA vs. 2.60.7mA p＜0.05).
Masson detection showed that the myocardial ﬁbrosis in PHA665752
group was obviously more severity than that in CSCs group.
CONCLUSIONS PHA665752, hepatocyte growth factor/c-Met inhibi-
tor, reduces the VFT and enhances the myocardial ﬁbrosis in MI rats
treated with CSCs transplantation, which indicates that CSCs para-
crining hepatocyte growth factor ameliorate myocardial ﬁbrosis
leading to VFT improvement.
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Changes of Small-conductance calcium-activated K(þ) channels 3 (SK3) in
Patients with Persistent Atrial Fibrillation
Qiang Xu,1 Miaoling Li,2 Tangting Chen,2 Huan Lan2
1Department of Histology and Embryology, Luzhou Medical College;
2The institute of Cardiovascular Research, Luzhou Medical College
OBJECTIVES We had reported that the current density of apamin-
sensitive SK channels was signiﬁcantly increased in AF group with
persistent atrial ﬁbrillation than SR group. The purpose of this
study was to investigate whether the current density increase of
SK channels in patients with persistent atrial ﬁbrillation was
because of its differential expression between the sinus rhythm (SR)
and persistent atrial ﬁbrillation patients and whether SK3 channel
is involved in electrical remodeling of human persistent atrial
ﬁbrillation.
METHODS The right atrial appendage myocytes were obtained from
16 sinus rhythm (SR) and 14 persistent atrial ﬁbrillation patients
